Company
Guardant Health Inc.
GHBiotechnology
Business description
Guardant Health Inc. is a precision oncology company that specializes in liquid biopsy tests for cancer detection, monitoring, and treatment. The company’s flagship product, Guardant360, drives revenue through diagnostic testing and strategic collaborations with healthcare providers and pharmaceutical firms. Led by CEO Helmy Eltoukhy, Guardant Health has established a competitive edge in genomic profiling within the molecular diagnostics market. It is now focused on expanding its product portfolio and global reach despite facing regulatory and market challenges.
$982M
Revenue (LTM)
2
Acquisitions
-44.5%
Operating margin
Q1 2026
Latest call
01 Explore
Everything on Guardant Health Inc.
Financials
Revenue (FY2025)
YoY growth
Operating margin
Direction
Gross margin
Net margin
Leadership & board
Helmy EltoukhyChairperson and Co-Chief Executive Officer
AmirAli TalasazDirector and Co-Chief Executive Officer
Ian ClarkLead Independent Director
Alex M. Azar IIDirector
Vijaya GaddeDirector
Manuel Hidalgo MedinaDirector
Meghan JoyceDirector
Steve KrognesDirector
Roberto MignoneDirector
Myrtle PotterDirector
Musa TariqDirector
Michael BellChief Financial Officer
Darya ChudovaChief Technology Officer
Craig EagleChief Medical Officer
Christopher FreemanChief Commercial Officer
Kumud KaliaChief Information Officer
Terilyn Juarez MonroeChief People Officer
John SaiaChief Legal Officer and Corporate Secretary
Acquisitions
Guardant Health acquires Guardant Health AMEA, Inc. (SoftBank joint-venture buyout)International precision oncology commercialization (Asia, Middle East and Africa) · 2022
View full deal
Guardant Health acquires MetaSight Diagnostics Ltd.Liquid-biopsy diagnostics technology / early cancer and disease detection · 2025
View full deal
Share repurchases
No active share-repurchase program disclosed; the only buyback was a one-time February 2025 treasury-stock repurchase of $45.0 million tied to the Note Exchange Transaction.
$45.0 million
Repurchased (latest FY)
Competitors
Named competitors
Bio-Reference Laboratories, Inc.Laboratory Corporation of AmericaQuest Diagnostics, Inc.